Rahmati Nezhad, P.; Riihilä, P.; Knuutila, J.S.; Viiklepp, K.; Peltonen, S.; Kallajoki, M.; Meri, S.; Nissinen, L.; Kähäri, V.-M.
Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers 2022, 14, 305.
https://doi.org/10.3390/cancers14020305
AMA Style
Rahmati Nezhad P, Riihilä P, Knuutila JS, Viiklepp K, Peltonen S, Kallajoki M, Meri S, Nissinen L, Kähäri V-M.
Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers. 2022; 14(2):305.
https://doi.org/10.3390/cancers14020305
Chicago/Turabian Style
Rahmati Nezhad, Pegah, Pilvi Riihilä, Jaakko S. Knuutila, Kristina Viiklepp, Sirkku Peltonen, Markku Kallajoki, Seppo Meri, Liisa Nissinen, and Veli-Matti Kähäri.
2022. "Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma" Cancers 14, no. 2: 305.
https://doi.org/10.3390/cancers14020305
APA Style
Rahmati Nezhad, P., Riihilä, P., Knuutila, J. S., Viiklepp, K., Peltonen, S., Kallajoki, M., Meri, S., Nissinen, L., & Kähäri, V.-M.
(2022). Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers, 14(2), 305.
https://doi.org/10.3390/cancers14020305